296 results on '"Rauck, Richard L."'
Search Results
2. Percutaneous 60-day peripheral nerve stimulation implant provides sustained relief of chronic pain following amputation: 12-month follow-up of a randomized, double-blind, placebo-controlled trial
3. Intrathecal Drug Delivery for Control of Pain
4. Unique aspects of clinical trials of invasive therapies for chronic pain
5. Long-term safety of spinal cord stimulation systems in a prospective, global registry of patients with chronic pain
6. Intrathecal Clonidine via Lumbar Puncture Decreases Blood Pressure in Patients With Poorly Controlled Hypertension
7. Intrathecal Drug Delivery for Control of Pain
8. Real-World Outcomes Using Spinal Cord Stimulation for Treatment of Chronic Pain in Non-Surgical Back Pain (NSBP) Patients
9. Treatment of Post-Amputation Pain With Peripheral Nerve Stimulation
10. Effectiveness and Safety of Intrathecal Ziconotide: Interim Analysis of the Patient Registry of Intrathecal Ziconotide Management (PRIZM)
11. Percutaneous Peripheral Nerve Stimulation for the Treatment of Chronic Low Back Pain: Two Clinical Case Reports of Sustained Pain Relief
12. Totally Implantable IV Treprostinil Therapy in Pulmonary Hypertension Assessment of the Implantation Procedure
13. Once-Daily Gastroretentive Gabapentin for Postherpetic Neuralgia: Integrated Efficacy, Time to Onset of Pain Relief and Safety Analyses of Data From Two Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Studies
14. Lubiprostone for Opioid‐Induced Constipation Does Not Interfere with Opioid Analgesia in Patients with Chronic Noncancer Pain
15. Opioid‐Induced Constipation Survey in Patients with Chronic Noncancer Pain
16. Past, Present, and Future of Informed Consent in Pain and Genomics Research: Challenges Facing Global Medical Community
17. Chronic Pain Syndromes in AIDS Patients
18. Response to Letter by Dr. Engel
19. Treatment of Opioid-Induced Constipation: Focus on the Peripheral μ-Opioid Receptor Antagonist Methylnaltrexone
20. Intrathecal Drug Delivery for Control of Pain
21. An Open-Label, Multicenter Study of the Safety and Efficacy of Intrathecal Ziconotide for Severe Chronic Pain When Delivered via an External Pump
22. Single-Entity Hydrocodone Extended-Release Capsules in Opioid-Tolerant Subjects with Moderate-to-Severe Chronic Low Back Pain: A Randomized Double-Blind, Placebo-Controlled Study
23. The Use of Contrast Agents in Interventional Pain Procedures: A Multispecialty and Multisociety Practice Advisory on Nephrogenic Systemic Fibrosis, Gadolinium Deposition in the Brain, Encephalopathy After Unintentional Intrathecal Gadolinium Injection, and Hypersensitivity Reactions
24. Intrathecal Drug Delivery for Control of Pain
25. Spinal Cord Stimulation
26. Contributors
27. Peripheral Nerve Stimulation for the Treatment of Postamputation Pain—A Case Report
28. List of Contributors
29. Compounding Intrathecal Drugs
30. The Delayed Appearance of Neurological Signs in Intrathecal Granuloma Warrants Imaging Surveillance: A Case Series and Review of the Literature
31. Successful Dose Finding with Sublingual Fentanyl Tablet: Combined Results from 2 Open-Label Titration Studies
32. Effectiveness and Safety of Intrathecal Ziconotide: Final Results of the Patient Registry of Intrathecal Ziconotide Management (PRIZM)
33. Complications Associated with Stellate Ganglion and Lumbar Sympathetic Blocks
34. What is the Case for Prescribing Long-Acting Opioids Over Short-Acting Opioids for Patients with Chronic Pain? A Critical Review
35. Intrathecal Ziconotide for Neuropathic Pain: A Review
36. Myofascial pain syndrome and fibromyalgia
37. Randomized, multi-center study of oral once-a-day AVINZA® (morphine sulfate extended-release capsules) vs. twice daily OxyContin® (oxycodone hydrochloride controlled-release) for the treatment of chronic moderate to severe low back pain.: 12E.
38. Cystatin C in cerebrospinal fluid is not a diagnostic test for pain in humans
39. Intrathecal drug delivery
40. Randomized Clinical Trial of an Implantable Drug Delivery System Compared With Comprehensive Medical Management for Refractory Cancer Pain: Impact on Pain, Drug-Related Toxicity, and Survival
41. An Updated Interdisciplinary Clinical Pathway for CRPS: Report of an Expert Panel
42. Long-term intrathecal opioid therapy with a patient-activated, implanted delivery system for the treatment of refractory cancer pain
43. Intrathecal, but not intravenous adenosine reduces allodynia in patients with neuropathic pain
44. Safety and tolerability of ALO-02 (oxycodone hydrochloride and sequestered naltrexone hydrochloride) extended-release capsules in older patients: a pooled analysis of two clinical trials
45. Percutaneous Peripheral Nerve Stimulation for the Treatment of Chronic Pain Following Amputation
46. I4 Effect of Intrathecal Ziconotide as the First Agent in Pump on Patient-Reported Outcomes
47. I3 Effectiveness and Safety of Intrathecal Ziconotide Use as the First Agent in Pump
48. Mitigation of IV Abuse Through the Use of Abuse‐Deterrent Opioid Formulations: An Overview of Current Technologies
49. Safety of oral methylnaltrexone for opioid-induced constipation in patients with chronic noncancer pain
50. Chronic Pain Syndromes in AIDS Patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.